A clinical trial shows the results of five years of CAR T-cell therapy for non-Hodgkin lymphomas
A large number of non-Hodgkin lymphoma (NHL) patients in a clinical trial initiated by Penn Medicine are still receiving relief five years after receiving the Kymriah cealla cell antigen receptor (…
_on_a_T-cell_is_binding_to_a_molecule_on_a_cancer_-_Alpha_Tauri_3D_Graphics_M1_dc8762afeaee4937ad644739f274c7a5-620x480.jpg)